These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions]. Sultan Y; Brouet JC Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682 [TBL] [Abstract][Full Text] [Related]
3. Proceedings: Prothrombin-complex concentrates, thromboses, and factor VIII inhibitors: evidence for a coagulant formed by the interaction of factors X and II. Tishkoff GH Thromb Diath Haemorrh; 1975 Nov; 34(2):589. PubMed ID: 1198500 [No Abstract] [Full Text] [Related]
4. Frequency of combined factor V and factor VIII deficiency in southern Iran. Haghpanah S; Karimi M Blood Coagul Fibrinolysis; 2013 Jun; 24(4):458-9. PubMed ID: 23632381 [No Abstract] [Full Text] [Related]
5. [Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX]. Iizuka A; Kuwashima M; Nagao T Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):987-92. PubMed ID: 6818811 [No Abstract] [Full Text] [Related]
6. Postpartum acquired factor VIII inhibitors. Franchini M Am J Hematol; 2006 Oct; 81(10):768-73. PubMed ID: 16868941 [TBL] [Abstract][Full Text] [Related]
7. The literature on inhibitors: articles that influence my management of patients with hemophilia A and high-titer inhibitors. Leissinger CA Am J Hematol; 2012 May; 87 Suppl 1():S23-6. PubMed ID: 22473571 [TBL] [Abstract][Full Text] [Related]
8. Factor VIII inhibitor. Nour-Eldin F JAMA; 1985 May 24-31; 253(20):2963. PubMed ID: 3923216 [No Abstract] [Full Text] [Related]
9. Treatment of refractory hemorrhage with Factor XIII in a patient with hemophilia A with inhibitor. Ng C; Silliman CC; Pearl G; Smith W; Manco-Johnson M; Wang M Pediatr Blood Cancer; 2013 Jul; 60(7):E23-5. PubMed ID: 23382082 [TBL] [Abstract][Full Text] [Related]
10. Progressing towards optimal management of haemophilia A patients with inhibitors. Foreword. Tarantino MD Haemophilia; 2013 Jan; 19 Suppl 1():1. PubMed ID: 23278992 [No Abstract] [Full Text] [Related]
11. Combined factor V-VIII deficiency: a case report with studies of factor V and VIII activation by thrombin. Hultin MB; Eyster ME Blood; 1981 Nov; 58(5):983-5. PubMed ID: 6794678 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment of chronic recurrent life-threatening bleeding due to an acquired factor V Inhibitor with rituximab and steroids. Patel MD; Hajdenberg J Haemophilia; 2016 May; 22(3):e231-2. PubMed ID: 27029965 [No Abstract] [Full Text] [Related]
13. Rituximab in the treatment of acquired hemophilia. Stachnik JM Ann Pharmacother; 2006 Jun; 40(6):1151-7. PubMed ID: 16735671 [TBL] [Abstract][Full Text] [Related]
14. [Development of inhibitors against factor VIII in patients with hemophilia A]. Cohn J; Nielsen VG Nord Med; 1971; 86(49):1495. PubMed ID: 5137039 [No Abstract] [Full Text] [Related]
15. FEIBA in haemophiliacs with factor VIII inhibitor. Thomas T; Williams H; Williams Y; Hunt J Br Med J; 1977 Jan; 1(6052):52. PubMed ID: 831997 [No Abstract] [Full Text] [Related]
16. Regulated release of VWF and FVIII and the biologic implications. Haberichter SL; Shi Q; Montgomery RR Pediatr Blood Cancer; 2006 May; 46(5):547-53. PubMed ID: 16470522 [TBL] [Abstract][Full Text] [Related]
17. A chamber of hope for hemophilia. Pipe SW; Kaufman RJ Nat Biotechnol; 2000 Mar; 18(3):264-5. PubMed ID: 10700134 [No Abstract] [Full Text] [Related]
18. Frequency of combined factor V and factor VIII deficiency in southern Iran. Mansouritorghabeh H Blood Coagul Fibrinolysis; 2014 Jan; 25(1):92-3. PubMed ID: 24370584 [No Abstract] [Full Text] [Related]
19. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group. Kessler CM; Ludlam CA Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193 [No Abstract] [Full Text] [Related]